Repeated cocaine exposure causes persistent, maladaptive alterations in brain and behavior, and hope for effective therapeutics lies in understanding these processes. We describe here an essential role for fragile X mental retardation protein (FMRP), an RNA-binding protein and regulator of dendritic protein synthesis, in cocaine conditioned place preference, behavioral sensitization, and motor stereotypy. Cocaine reward deficits in FMRP-deficient mice stem from elevated mGluR5 (or GRM5) function, similar to a subset of fragile X symptoms, and do not extend to natural reward. We find that FMRP functions in the adult nucleus accumbens (NAc), a critical addiction-related brain region, to mediate behavioral sensitization but not cocaine reward. FMRP-deficient mice also exhibit several abnormalities in NAc medium spiny neurons, including reduced presynaptic function and premature changes in dendritic morphology and glutamatergic neurotransmission following repeated cocaine treatment. Together, our findings reveal FMRP as a critical mediator of cocaine-induced behavioral and synaptic plasticity.
INTRODUCTION
Recent evidence suggests that exposure to drugs of abuse, as well as other experiences (e.g., motor learning, novel environment, and whisker trimming), alter synaptic connectivity by influencing both the strengthening and formation, as well as the weakening and elimination, of glutamatergic synapses. Drug-induced alterations in connectivity are likely important because they can be long lasting and may underlie aspects of addiction-related behaviors (Lee et al., 2006; Li et al., 2004) . In rodent models of drug use, increased dendritic spine density (Lee et al., 2006; Li et al., 2004; Norrholm et al., 2003; Robinson and Kolb, 1999) and synaptic strength (Kourrich et al., 2007) of dopaminoreceptive medium spiny neurons (MSNs) in the nucleus accumbens (NAc) have been widely reported. The presence, degree, and longevity of these synaptic changes appear to depend on several factors such as drug dose, length of exposure and withdrawal, MSN subtype, and NAc subregion. However, factors controlling drug-induced synaptic plasticity remain elusive. Here, we identify a role for the RNA-binding protein, fragile X mental retardation protein (FMRP), as a key regulator of synaptic and behavioral alterations following exposure to cocaine (COC).
The molecular and cellular mechanisms that control excitatory synapse number remain poorly understood. We and others have reported that the myocyte enhancer factor 2 (MEF2) family of transcription factors negatively regulates glutamatergic synapse and dendritic spine number in hippocampal neurons (Flavell et al., 2006) . We extended these findings to the adult NAc in vivo, showing that MEF2 regulates the dendritic spine density of NAc MSNs basally and that chronic COC administration can increase NAc MSN spine density, at least in part, by inhibition of MEF2 (Pulipparacharuvil et al., 2008; Zhang et al., 2012) . Most recently, we reported that MEF2-induced synapse elimination in hippocampal neurons requires the RNA-binding capabilities of FMRP (Pfeiffer et al., 2010) and a complex molecular mechanism involving the MEF2 target gene, Pcdh10, and targeted degradation of the synaptic scaffold protein, PSD-95 (Tsai et al., 2012) .
FMRP regulates the transport, stability, and/or translation rate of more than 850 brain mRNAs, many of which are linked to synaptic function (Darnell et al., 2011) . Loss of FMRP expression in humans, as occurs in fragile X syndrome (FXS), results in a variety of neurological symptoms, including sensory hypersensitivity, intellectual disability, and often, autism-associated behaviors and/or epilepsy (for review, see Hagerman, 2006) . In dendrites, FMRP regulates local protein synthesis of associated mRNAs, at least in part, by stalling translation on polyribosomes (Ceman et al., 2003; Darnell et al., 2011; Stefani et al., 2004) . Glutamate-dependent activation of group I metabotropic glutamate receptors (mGluR1 and mGluR5 [also known as GRM1 and GRM5]) increases local protein synthesis through transient dephosphorylation and degradation of FMRP (Ceman et al., 2003; Nalavadi et al., 2012; Narayanan et al., 2007) ; so, in part, FMRP serves as a critical gate to processes downstream of mGluR5, ensuring that their activation occurs under appropriate conditions. Several studies have reported an important role for FMRP in regulating mGluR5-dependent synaptic weakening (long-term depression; LTD) (Huber et al., 2002; Narayanan et al., 2007; Weiler and Greenough, 1999) , for example, and proper mGluR5 function is required for several COC-related behaviors (Chiamulera et al., 2001; Olsen et al., 2010) . As such, we sought to test whether FMRP regulates COC-induced behavioral and synaptic plasticity in vivo.
RESULTS

FMRP Is Required for the Development of COC-Induced Behavioral Sensitization
To test the role of FMRP in behavioral responses to repeated COC administration, we compared behavioral sensitization in Fmr1 knockout (KO) mice to wild-type (WT) littermates. Behavioral sensitization results from enduring and functional neuroadaptations in the NAc and reward-related circuitry that are hypothesized to underlie the transition to compulsive drugseeking and drug-taking behavior in addiction (Koob and Volkow, 2010 ). Using either moderate or high doses of COC (daily intraperitoneal [i.p.] injections at 15 or 30 mg/kg for 7 days), we observed that, while both groups showed sensitization to COC, WT mice achieved significantly higher levels of behavioral sensitization than Fmr1 KO mice (Figures 1A-1D ; see statistics listed in Table S1 available online). It is interesting that COC injections on the first few days elicited similar locomotor responses in both WT and Fmr1 KO mice, suggesting that FMRP is not required for initial COC-induced activity or early sensitization but is required for the mechanisms controlling maximal motor sensitization after repeated exposures. Once developed, reduced sensitized responses in Fmr1 KO mice were also observed after 3 to 7 days of withdrawal, at several different COC challenge doses (7.5, 15, and 30 mg/kg; Figures 1B and 1D) , and at 4 and 10 total months of withdrawal (Figure 1D) . In contrast, neither the sensitized locomotion to context alone (saline [SAL] ; Figure 1B , ''0'' challenge) nor the activity during noninjection trials (habituation trials in Figures S1A and S1B) were different between genotypes.
Since the observed group differences could result from hypersensitivity to COC-induced stereotypy in Fmr1 KO mice, we used a time-sampling approach (Kelley, 1998) to evaluate SAL-or COC-induced stereotypy in Fmr1 KO and WT littermates, scoring behaviors both individually and on a published scale (Spangler et al., 1997) . While WT and Fmr1 KO littermates did not differ after repeated SAL or acute, high-dose COC (30 mg/ kg) on any stereotypy-related assessments, Fmr1 KO mice showed significantly greater stereotypy after repeated highdose COC ( Figure 1F , ''Repeated''; for matching locomotion, see Figures 1G and S1E). More detailed analysis showed that the heightened stereotypy involved primarily orofacial behaviors (i.e., taffy pulling and paws to mouth; Figure 1H ), but not grooming-or sniffing-related activities ( Figures S1F and S1G ). In contrast, stereotypy was not heightened in Fmr1 KO mice following a lower dose challenge (15 mg/kg; Figure 1F , ''Challenge''), even though locomotor activity remained significantly impaired (last challenge in Figure 1D ). To determine whether the increase in stereotypy at 30 mg/kg could reflect a general hypersensitivity to COC in Fmr1 KO mice, we also assessed sensitization using two lower doses of COC (5 and 10 mg/kg). While both genotypes sensitized to each dose, there were no locomotor differences between the groups (Figures S1C and S1D), indicating that Fmr1 KO mice are not hypersensitive to COC in general. Together, these data suggest that loss of FMRP impairs behavioral sensitization at moderate COC doses but enhances the development of stereotypy at higher COC doses.
Deficits in the cyclic AMP (cAMP) signaling cascade have previously been shown in Fmr1 KO mice (Wang et al., 2008) , which could be relevant to our observations regarding sensitization. To address this possibility, we examined phosphorylation of the serine-845 site of glutamate receptor 1 (GluA1), a (B) Fmr1 KO mice show a significant deficit in sensitized locomotion to COC (15 mg/kg) compared to WT littermates (n = 13 WT, 11 KO), while activity after the first (acute) exposure does not differ. Deficits are also present at all COC challenge doses-15, 7.5, and 30 mg/kg-but not at the SAL challenge. Fmr1 KO mice also show a trend toward significantly enhanced locomotor activity after SAL injections. (C) Timeline for 30 mg/kg sensitization. d, days; m, months. (D) Fmr1 KO mice show deficits in locomotor sensitization to 30 mg/kg COC that are not present acutely and that extend to challenges at different time points: 30 mg/kg at 1-week withdrawal and 15 mg/kg at 4 and 10 months cumulative withdrawal (n = 12 WT, 12 KO). Cumulative beam breaks for the first 20 min of each daily trial after injection are shown. (E) Top: composite illustration demonstrating time points (arrows) for stereotypy analysis after injection. Bottom: arrows and boxes illustrate example time sampling method (see Experimental Procedures). sec, seconds; chal, challenge; min, minute. (F-H) In (F), average median stereotypy scores are shown for WT and Fmr1 KO littermates using a modified scale (Spangler et al., 1997) (OS, orofacial stereotypy) . Fmr1 KO mice show a significantly higher score after repeated high-dose COC treatment (n = 12 KO, 12 WT) but not after a lower dose challenge after long-term withdrawal. (G) Hand-scored locomotor activity during stereotypy analysis. (H) The increased stereotypy observed in Fmr1 KO mice after repeated COC treatment is largely made up of orofacial behaviors (composite score: paw-to-mouth movements + taffy pulling). Asterisks refer to significant follow-up Bonferroni post hoc tests; column abbreviations denote within-group differences of the labeled bar compared to noted day (S4, SAL Day 4; C1, COC Day 1; C4, COC Day 4). # p < 0.10, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001; data shown are mean ± SEM. See also Figure S1 and Table S1 .
downstream target of this cascade, in Fmr1 KO and WT littermates after a COC dosing regimen similar to that used for sensitization testing. We observed a similar induction of P-S845 levels in WT and KO mice striata after acute or chronic COC dosing ( Figure S1H ), suggesting that a deficit in COC-induced activation of cAMP/protein kinase A-dependent signaling in the striatum is unlikely to account for the behavioral alterations that we observed. Figure S2 and Table S1 .
FMRP Is Required for the Development of COC-Related Reward Learning
To test whether FMRP influences other types of COC-induced behaviors, we examined COC reward in a naive cohort of WT and Fmr1 KO mice using the COC conditioned place preference (CPP) assay. In this assay, mice are injected with either COC (7.5 mg/kg) or SAL and placed in one of two contextually distinct chambers on conditioning days. On preand posttest days, mice are placed into the center chamber and allowed to freely explore all three chambers for 20 min, and time spent in the COC-paired chamber minus time spent in the SAL-paired chamber is defined as COC preference. Similar to the locomotor sensitization results, we observed a significant reduction in preference for the COC-paired chamber in Fmr1 KO mice ( Figure 2B ), suggesting that FMRP is required for COC reward and/or learning and memory of context-drug associations. Similar to the behavioral sensitization findings, the COC reward deficit disappeared at a lower dose (5 mg/kg), where both WT and KO mice showed reduced, but comparable, preference for the drug-paired chamber ( Figure S2A ). Consistent with demonstration of normal reward learning at lower doses of COC, we observed that Fmr1 KO mice showed normal context-and cue-induced freezing at 24 hr after receiving three mild, aversive foot shocks in the standard fear conditioning assay (Figures 2C and S2B) , suggesting that Fmr1 KO mice are able to remember a salient stimulus-context association in a timeframe similar to that used in the COC CPP assay.
Given that Fmr1 KO mice model a clinical condition, FXS, we next asked whether deficits in COC reward behaviors would extend to natural reward, which would have important implications for this patient population. To assess this possibility, we used the same COC CPP chambers to test WT and Fmr1 KO mice for palatable food-based CPP. Both genotypes showed equivalent preference for high-fat chow compared to regular chow ( Figures 2D and 2E ). Similarly, we observed no genotype differences in the preference for sucrose at multiple concentrations (Figures 2F and S2C) in the standard two-bottle choice test. Together, these results suggest that FMRP is not required for all reward-related behaviors and may be more specific to drug reward behavior.
A number of FXS-related phenotypes have now been attributed to hyperactivity or hypersensitivity of mGluR5 (Dö len et al., 2007) , and manipulating mGluR5 activity has been shown to alter drug reward behaviors (Olive, 2009; Rutten et al., 2011) . Therefore, we used a gene dosage approach to test whether mGluR5 hyperfunction might contribute to the observed deficit in COC reward behavior in Fmr1 KO mice. While mice lacking one copy of the mGluR5 gene (mGluR5 +/À ) had normal COC reward learning behavior, reducing mGluR5 levels did rescue the Fmr1 KO deficit ( Figure 2G ), suggesting that Fmr1 KO impairments in COC CPP stem from mGluR5 hyperactivity. Taken together, these results suggest that mice lacking FMRP have reduced sensitivity to the rewarding impact of moderate dose COC.
FMRP Is Required in the Adult NAc for Behavioral Sensitization but Not Drug Reward
In the adult brain, the NAc is a critical brain region for the development and expression of COC reward and behavioral sensitization. Fmr1/FMRP is expressed in the adult NAc (Allen Institute for Brain Science, 2014; Figures S3C and S3D) . To test whether FMRP in the adult NAc is required for the rewarding and behavioral effects of repeated COC administration, we performed bilateral injections of AAV2-Cre-GFP or AAV2-GFP control viruses in the NAc of adult floxed Fmr1 mutant mice (Mientjes et al., 2006) to generate conditional KO of Fmr1 (NAc cKO) in the adult brain ( Figure 3A ). The Fmr1 NAc cKO and control mice were then tested for COC reward and behavioral sensitization, as indicated ( Figure 3B ). Neither conditional NAc deletion of Fmr1 ( Figure 3C ) nor conditional deletion of Fmr1 in dopaminergic neurons (DAT-Cre:Fmr1 fl/y ; Figure S3A ), caused a significant deficit in COC reward behavior, suggesting that the observed COC reward deficit in Fmr1 KO mice is due to a role for FMRP in additional brain region(s) and/or to a developmental role for FMRP. In contrast, the Fmr1 NAc cKO mice showed a significant reduction in COC-induced behavioral sensitization ( Figures 3D and S3B ) reminiscent of the effect observed in Fmr1 total KO mice after repeated COC exposure, suggesting strongly that FMRP plays an active role in the adult NAc to mediate the plasticity underlying behavioral sensitization.
In contrast to other factors implicated in COC-induced behavioral plasticity that appear to be regulated by COC (e.g., DFosB), we did not observe any evidence that FMRP mRNA or protein levels were altered by repeated COC administration at 24 hr after the last injection of either 15 or 30 mg/kg ( Figures S3C  and S3D ). These findings indicate that FMRP's function in mediating the normal development of behavioral sensitization does not likely involve changes in its basal levels. Taken together, our combined data suggest that FMRP functions in the adult NAc to mediate behavioral plasticity induced by repeated, moderate-to-high dose COC, but its role in COC reward behavior is more complex.
FMRP Limits COC-Induced Increases in Structural Alterations in the NAc
Numerous studies have reported that repeated, high-dose COC exposure induces structural and synaptic plasticity in MSNs of the NAc, and some of these changes have been proposed to support or antagonize COC behaviors. FMRP is known to regulate synapse weakening and to promote dendritic spine and excitatory synapse elimination (Pfeiffer et al., 2010; Weiler and Greenough, 1999) , as well as to control proper dendritic branch extension and pruning (Thomas et al., 2008) . To explore FMRP's role in repeated COC-induced structural plasticity in the NAc, we injected WT and Fmr1 KO mice with repeated daily COC or SAL in the same manner as described previously (i.e., 15 mg/kg daily COC injections 3 7 days; Figure 4A ). We analyzed MSNs 24 hr after the last injection since (1) maximal behavioral sensitization has been fully established by this time, (2) behavioral sensitization differences between WT and Fmr1 KO mice are established and persistent through short-or long-term withdrawal, and (3) any relevant structural or functional changes in the NAc that regulate behavioral sensitization must also be present. Using a well-established Golgi staining procedure, we used stereomicroscopy to reconstruct MSNs from the NAc core or shell regions ( Figure 4B ). In the core subregion of Fmr1 KO mice, we observed that repeated COC exposure induced a significant increase in the number and total length of dendritic branches (Figures 4C and 4D) . In contrast, no significant changes were observed in shell MSN dendritic branching morphology for WT or Fmr1 KO mice after repeated COC exposure ( Figures S4A and S4B) .
We next analyzed dendritic spine density in core and shell MSNs in both WT and Fmr1 KO mice. In the core, we observed no alterations in dendritic spine density in WT or KO mice after repeated COC administration; however, there was a modest increase in overall core MSN spine density in Fmr1 KO mice compared to WT ( Figure S4C , inset), which reached significance for the thin spine category ( Figure S4C ). Similar to the core, we observed no COC-induced changes in overall net dendritic spine density in shell MSNs from WT mice ( Figure 4E , inset). While others, including our group, have observed COC-induced changes in this region, we note that most published studies have used higher doses of COC (20-30 mg/kg COC) and longer administrations. In contrast to the WT littermates, repeated COC exposure did significantly increase overall shell MSN spine density in Fmr1 KO mice ( Figure 4E , inset). Closer examination revealed that thin and stubby spine subtypes were increased after COC treatment in Fmr1 KO mice, whereas no spine subtypes were altered by COC in WT mice. Together, these findings suggest that FMRP normally functions to antagonize the formation of NAc dendritic spines and branching in response to COC exposure, which is consistent with its known role as a mediator of dendritic pruning and spine elimination (Pfeiffer et al., 2010; Weiler and Greenough, 1999) . The findings reveal that an overall increase in NAc core or shell MSN spine density is not strictly required for the development and short-term expression of behavioral sensitization. Moreover, the precocious increase in dendritic spine density in NAc shell in the Fmr1 KO mice after repeated COC exposure correlates with a decrease in sensitized locomotion after short-term withdrawal, similar to several other reports Norrholm et al., 2003; Pulipparacharuvil et al., 2008) . (C) Loss of NAc FMRP does not recapitulate the reduction in CPP observed in total Fmr1 KO mice (7.5 mg/kg; n = 18 AAV-CRE-GFP, 22 AAV-GFP). sec, seconds. (D) Floxed-Fmr1 conditional KO mice injected with AAV-CRE-GFP show a significant deficit in COC sensitization (15 mg/kg) compared to those injected with AAV-GFP, which is not significant at acute exposure (n = 18 AAV-CRE-GFP, 22 AAV-GFP). Cumulative beam breaks for the first 20 min of each daily trial after injection are shown. ns, not significant; **p < 0.01. Data shown are mean ± SEM. See also Figure S3 and Table S1 .
FMRP Limits COC-Induced Increases in Synaptic Function in the NAc Shell
We next investigated the role of FMRP in regulating synaptic transmission in NAc shell MSNs by measuring miniature excitatory postsynaptic currents (mEPSCs) under the same conditions used to analyze behavioral sensitization and dendritic spine density. Consistent with our shell spine analysis ( Figure 4E ), we failed to observe an effect of repeated COC on the mEPSC frequency in WT mice. However, similar to the dendritic spine observations, we found that repeated COC administration significantly increased mEPSC frequency in Fmr1 KO mice ( Figure 5A ). Paired-pulse ratio (PPR) in Fmr1 KO mice was not significantly altered by repeated COC exposure ( Figure 5B ), suggesting that the observed increase in mEPSC frequency is likely due to an increase in dendritic spine synapses. Notably, we also observed that the mEPSC frequency was reduced in SAL-treated Fmr1 KO mice when compared to SAL-treated WT mice, suggesting a basal decrease in functional synapse number (e.g., as noted for stubby spine density; Figure 4E ) and/or a deficit in presynaptic function in the Fmr1 KO mice. Indeed, when we measured PPRs from WT and Fmr1 KO mice ( Figure 5B ; Figures S5A and S5B), Fmr1 KO mice showed an increased ratio, indicating a deficit in presynaptic release on to NAc shell MSNs compared to WT mice ( Figure 5B ).
Recent evidence also demonstrates that repeated COC administration alters postsynaptic function by increasing a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) surface expression. To assess the effects of COC on postsynaptic AMPAR function in WT and Fmr1 KO mice, we measured and analyzed mEPSC amplitudes ( Figure 5D ). It is interesting that chronic COC significantly increased mEPSC amplitude in the Fmr1 KO MSNs but had no effect on mEPSC amplitude in WT MSNs at the 24 hr withdrawal time point. To gain additional confidence regarding the role of AMPARmediated transmission in the COC-induced increase in mEPSC amplitude in Fmr1 KO mice, we examined the ratio of AMPARs to N-methyl-D-aspartate receptors (NMDARs) in KO shell MSNs at this same time point ( Figure 5E ). As expected, COC treatment increased the AMPAR/NMDAR ratio in Fmr1 KO mice. These findings suggest that FMRP antagonizes both net spine density increases and AMPAR-mediated synaptic transmission in the NAc shell in response to chronic COC and that, in WT mice, cellular mechanisms that promote synapse strengthening and synaptogenesis are equally balanced, at least at this COC dose and time point, by synapse weakening and elimination processes that require FMRP.
DISCUSSION
Chronic exposure to drugs of abuse induces changes in synapse structure and function that are thought to underlie addictionrelated behavioral plasticity. However, the cellular and molecular mechanisms that mediate behaviorally relevant plasticity in brain reward circuitry remain poorly understood. We show here that FMRP, an RNA binding protein that regulates dendritic pruning and synapse weakening/elimination, regulates these processes in NAc core and shell MSNs after COC exposure and is critically involved in the development of multiple COC-induced behaviors.
Specifically, loss of FMRP impairs both COC-induced reward and behavioral sensitization, apparently via its function in multiple, possibly distinct, brain regions. While FMRP is required acutely in the adult NAc for the development of behavioral sensitization, its absence either in the NAc or in dopaminergic neurons is not sufficient to impair COC reward. Instead, deficiencies in drug-induced reward appear to relate to general hyperactivity of mGluR5 function in Fmr1 KO mice, since genetic reduction of mGluR5 expression rescues this deficit. In FMRP-deficient mice, a sensitizing regimen of COC induces significant changes in NAc shell and core MSNs that are observable 24 hr after the last exposure. Without FMRP, repeated COC exposure increases the number of structural and functional synapses and synaptic strength of NAc shell MSNs, while core MSNs undergo COC-induced increases in dendritic branching and length. In contrast, despite robust behavioral sensitization, COC-induced changes in net NAc spine density and synaptic strength are not observed in WT mice at this time point and COC dose, suggesting that these changes, at least on the global NAc MSN population, are not required for the development and short-term expression of behavioral sensitization. In the process of describing FMRP's role in COC-induced behavioral and synaptic plasticity, we also add to a small, but growing, literature defining striatal abnormalities in FXS and reveal, in a unique setting, how experience-dependent synaptic plasticity goes awry in its absence-observations that may have relevance to FXS-associated motor, learning, and behavioral abnormalities.
Our findings with regard to COC reward in Fmr1 KO mice are intriguing for several reasons. First, our mGluR5 genetic rescue study suggests that the reduced COC reward behavior in the Fmr1 KO mice is a result, at least in part, of elevated mGluR5 levels or function, a well-described feature of FXS (Bear et al., 2004; Osterweil et al., 2010) . Genetic/pharmaceutical reduction of mGluR5 expression/activity reverses most, but not all, of the observed morphological, behavioral, and functional plasticity deficits in FXS (Dö len et al., 2007; Pop et al., 2014) ; here, we find that it also rescues COC reward dysfunction in Fmr1 KO mice. Of note, mGluR5 antagonists are also being explored as potential therapeutics for addiction based on their ability to reduce drug-motivated behaviors such as CPP (for review, see Olive, 2009 ), although it is not yet clear whether they achieve this effect by reducing reward sensitivity or via reward substitution (Rutten et al., 2011) . Our findings that reducing mGluR5 levels in the Fmr1 KO restores normal COC reward behavior suggest that mGluR5's regulation of COC reward is nonlinear, so that too much, too little, or constitutive mGluR5 activity might alter drug reward sensitivity.
Given that FXS is associated with intellectual impairment in human patients and mice, we tested whether the COC reward deficit was a result of reduced learning/memory. However, Fmr1 KO mice made normal contextual associations with both mildly aversive and naturally rewarding stimuli, as well as with a lower dose of COC (i.e., 5 mg/kg). These findings are in general agreement with several other studies showing little or no learning impairments in Fmr1 KO mice on the C57BL/6 background (Dobkin et al., 2000; Paradee et al., 1999) and suggest that deficits in COC reward are not due to general defects in contextual learning. A second implication from our findings concerns the role of FMRP in brain reward function and plasticity. We did not observe evidence for reduced natural reward in Fmr1 KO mice, at least with respect to food-based incentives; however, analysis of other types of reward deficits that have relevance to FXS, such as social reward, will be important to explore in the future.
Our close examination of behavioral sensitization in Fmr1 KO mice highlights the complex interrelationship between COCinduced locomotor sensitization and motor stereotypies. Since deficits in sensitized locomotion only became apparent in Fmr1 KO mice at higher doses (15 and 30 mg/kg) of COC and only after repeated exposures, we suspected that the reduced activity in Fmr1 KO mice could be a result of enhanced stereotypy behavior competing with locomotion. Indeed, the decrease in locomotion seen over daily repeated high doses of COC (30 mg/kg) in both genotypes is almost certainly a result of competing stereotypy that develops over several days of drug exposure, and at this high dose, Fmr1 KO mice develop enhanced stereotypy behavior more rapidly and/or to a greater extent than WT mice. However, increased stereotypy in Fmr1 KO mice was only observed at the highest dose (30 mg/kg), suggesting that the reduction in locomotion observed at 15 mg/kg is not a result of potentiated stereotypy. Furthermore, at lower doses of COC (5 and 10 mg/kg), Fmr1 KO mice show a similar development of behavioral sensitization to WT mice, arguing against a general hypersensitivity to COC that reduces locomotion at the 15 mg/kg COC dose. Together, these findings suggest that FMRP contributes to the normal development of both sensitized locomotion and stereotypy behaviors but in a dosesensitive manner. Previous studies have primarily attributed locomotor activation to the ventral striatum (including the NAc) and the development of stereotypy to the dorsal striatum (Joyce and Iversen, 1984) ; therefore, it seems likely that FMRP is regulating the development of sensitized locomotion in the NAc, consistent with our conditional Fmr1 KO data ( Figure 3D ), but regulating the development of motor stereotypies in the dorsal striatum (or other regions). Notably, heightened repetitive or stereotypical behaviors are a central feature of FXS and, more broadly, of autism spectrum disorders. While we did not observe COC-independent differences in stereotypy between WT and KO mice, it is interesting to speculate that the enhanced COCinduced stereotypy behavior in Fmr1 KO mice results from subtle dysfunction in the striatal circuit that regulates repetitive motor behaviors. In the future, it will be interesting to examine how the role and regulation of FMRP in striatal subregions affect motor stereotypies.
Abnormalities in dendritic morphology have been repeatedly observed in both patients and animal models of FXS, including increased basal densities of (especially immature) dendritic spines (Hinton et al., 1991; Irwin et al., 2000 Irwin et al., , 2001 Irwin et al., , 2002 Kooy, 2003; Liu et al., 2011) and altered dendritic branch number and length (Guo et al., 2011; Lee et al., 2003; Restivo et al., 2005) . However, basal spine density in FXS has, thus far, largely been studied in the cerebral cortex and hippocampus. We report here that FMRP-deficient MSNs, which are GABAergic projection neurons, show no basal spine density alterations in the NAc shell and only a very small increase in the NAc core. While FMRP's spine-regulating function in MSNs could be distinct from its role in pyramidal glutamatergic neurons, we also reason that basal spine density may be altered by resting-state activity in different brain regions. Many of FMRP's functions are activity dependent, including dendritic transport (Dictenberg et al., 2008) , spine/synapse elimination (Pfeiffer et al., 2010) , and LTD (Huber et al., 2002) , and NAc MSNs have a highly negative resting membrane potential and require strong afferent activity to reach spike threshold (Pennartz et al., 1994) . Despite the lack of strong basal differences in WT and Fmr1 KO MSNs, when a moderate, sensitizing regimen of COC is given, we see that FMRP-deficient mice produce what appear to be precocious net increases in branching and structural and functional synapse number, as well as synaptic strength. Specifically, we observed increases in thin and stubby spine subtypes in the NAc shell of Fmr1 KO mice at this short, 24 hr withdrawal time point, the same spine subtypes observed to be increased in WT rats after 2 weeks of withdrawal from similar COC exposure (Wang et al., 2013) . Even though dendritic spine density did not change in the NAc core MSNs after COC exposure, we note that the increase in branch complexity and length may translate to an overall increase in core dendritic spine number as well. Similarly, the increases in synaptic strength (i.e., mEPSC amplitude and AMPA/NMDA receptor ratio) that were observed in NAc shell MSNs of Fmr1 KO mice after COC exposure are highly reminiscent of those typically observed in WT rodents after longer term (i.e., 7-to 21-day) COC withdrawal (Boudreau and Wolf, 2005; Kourrich et al., 2007) .
The functional relevance of these precocious synapse-related changes in Fmr1 KO mice is intriguing since the WT, littermate (D) In keeping, the total length of third-and fourth-order core MSN branches was increased by COC in Fmr1 KO, but not WT mice, and fourth-order branch length was increased in KO compared to WT MSNs after COC but not SAL. Symbols indicate significant simple main effects of genotype (u) and treatment (d).
(E) An increase in overall spine density of NAc shell MSNs was seen in Fmr1 KO mice, but not WT mice, after COC (inset). Analysis by spine type revealed a basal decrease in KO SAL stubby spine density compared to WT SAL, accompanied by a strong trend toward a significant increase in branched spines in KO compared to WT SAL-treated mice. COC treatment increased both stubby and thin spine densities in KO mice compared to SAL treatment. While COC treatment ''rescued'' a low basal density of stubby spines in Fmr1 KO mice to no different than in either WT group, thin spine density was significantly elevated above that of WT COC. Asterisks refer to significant follow-up univariate ANOVAs. Focused images were created using an ImageJ Extended Depth of Field plug-in (Aguet et al., 2008) (http://imagej.nih.gov/ij/). Scale bar, 50 mm.
# p < 0.10, *p < 0.05, **p < 0.01, and ***p < 0.001; ns, not significant. Data shown are mean ± SEM. See also Figure S4 and Table S1 .
control mice did not increase structural or functional synapses in the NAc shell (or structural in core), despite developing robust behavioral sensitization. Whether and how COC-induced spine density-in particular, in the NAc-is related to drug-induced behaviors, especially behavioral sensitization and COC reward, remain long-standing and largely unresolved questions in the addiction field (Rothenfluh and Cowan, 2013; Russo et al., 2010) . A number of previous studies, including one from our own lab, reported molecular or genetic manipulations that regulated COC-induced dendritic spine density and behavioral sensitization. While some inversely alter Norrholm et al., 2003; Taylor et al., 2007; Waselus et al., 2013) or even dissociate the two (Kiraly et al., 2010; Pulipparacharuvil et al., 2008; Wang et al., 2013) , other manipulations positively regulate both spines and behavior (Dietz et al., 2012; Kelz et al., 1999; Maze et al., 2010) . Similar to the Dnmt3a KO mice (LaPlant et al., 2010), Fmr1 KO mice show a selective increase Figure S5 and Table S1 .
in ''thin'' dendritic spines after COC treatment compared to WT mice, and in both studies, this increase is associated with reduced behavioral sensitization. However, in all of the studies on this subject, the primary manipulation is specifically on the molecule/gene, which can have many cellular functions that influence behavioral sensitization independent of COC-induced changes in dendritic spines. Similar to our current findings, a recent report suggests that the dendritic spine density increase is not required for behavioral sensitization but does underlie incentive sensitization (Wang et al., 2013) , a process whereby COC experience increases later sensitivity to COC reward. A relationship between COC-induced alterations in NAc spine density and CPP has also been proposed (Dietz et al., 2012; Marie et al., 2012; Maze et al., 2010; Russo et al., 2009 ). While we did not specifically look at dendritic spine density changes in WT or Fmr1 KO mice under COC CPP conditions (e.g., 7.5 mg/kg COC 3 2 injections), we suspect that changes in WT mice would not be observed under these low-dose conditions; however, in the future, it will be important to test this idea more directly.
The lack of change in the AMPAR-mediated synaptic transmission of our WT mice treated with COC is consistent with previous studies showing that repeated daily COC administration does not increase overall NAc glutamatergic synaptic strength (synaptic AMPAR surface expression or AMPA/NMDA receptor ratio) in WT mice after short-term (i.e., 1 day) withdrawal (Boudreau and Wolf, 2005; Kourrich et al., 2007) and supports the idea that global changes in overall NAc glutamatergic synapse strength are not required for the short-term expression of behavioral sensitization (Boudreau et al., 2007) . Instead, timedependent increases in synaptic potentiation have been suggested to promote withdrawal-associated behaviors, such as incubation of drug craving (Conrad et al., 2008) , as well as withdrawal-dependent locomotor sensitization after a single previous exposure (Pascoli et al., 2012) ; therefore, it may be important to investigate such behaviors in the Fmr1 KO mice in the future. Also, recent studies report that repeated COC exposure triggers the generation of transient, silent synapses in the NAc after short-term withdrawal (Huang et al., 2009; Koya et al., 2012) . It will be interesting to determine if FMRP contributes to the generation or duration of silent synapses in the future.
One interesting finding in our study is basal reduction in presynaptic function of glutamatergic inputs on to NAc shell MSNs in Fmr1 KO mice. While its presynaptic role is not well understood, FMRP is present in axons, including in presynaptic compartments, particularly in neurons undergoing high levels of activity-dependent plasticity, such as that seen during brain development, reinnervation after injury, and adult neurogenesis Christie et al., 2009) . FMRP binds approximately one third of the mRNAs known to encode proteins in the mouse presynaptic proteome (Darnell et al., 2011) . COC CPP was normal when FMRP was selectively deleted from either the adult NAc or in all dopamine-transporter-expressing, dopaminergic neurons, suggesting that loss of presynaptic FMRP in NAc afferents, during either development or adulthood, might contribute to the COC reward deficit in the Fmr1 KO mouse. However, it is not yet clear whether or how the observed presynaptic function deficit in naive Fmr1 KO mice affects any of the observed behavioral or synaptic plasticity changes seen after COC administration. It will be interesting to investigate the potential contribution of presynaptic alterations in FMRP-deficient mice in the COC-induced behavioral and synaptic changes in future studies.
Overall, our data reveal an essential role for FMRP in the adult NAc to facilitate behavioral plasticity to repeated COC exposure, possibly via its negative regulation of MSN structural and functional synapse number and strength during repeated COC exposure. Through this process, we help to elucidate FMRP's role in the ventral striatum and how its absence alters experience-driven plasticity, which has implications for understanding the abnormal brain function and plasticity that contribute to symptoms of FXS. Our findings suggest that FMRP-dependent synapse weakening and elimination are important for the development of repeated COC-induced behavioral plasticity and reveal an important role for FMRP or one of its regulated processes (local protein synthesis, dendritic RNA trafficking, AMPAR endocytosis and LTD, MEF2-dependent synapse elimination, etc.) in the establishment of stable drug-induced behaviors. As such, FMRP or one of its associated and regulated mRNAs, may be a desirable therapeutic target for the treatment of drug addiction.
EXPERIMENTAL PROCEDURES
Detailed methods are given in the Supplemental Experimental Procedures.
Animals and Drugs
Experimental procedures were approved by Institutional Animal Care and Use Committees at the University of Texas Southwestern Medical Center, McLean Hospital, or the University of Minnesota. COC HCl was dissolved in 0.9% NaCl (vehicle).
Locomotor Sensitization
Activity was collected via photobeam arrays (San Diego Instruments) before and after injection. Mice received SAL for 3-4 days and COC (5, 10, 15, or 30 mg/kg) for the next 7 days. After 1 (10, 15, and 30 mg/kg) or 2 weeks (5 mg/kg), a same-dose COC challenge was given, followed by additional challenges (see timelines in Figures 1A, 1C , and 3B; Supplemental Experimental Procedures). Data shown are the sum of total beam breaks over the first 20 or 30 min of each trial.
Stereotypy Analysis
During the indicated locomotor trials, mouse behavior was scored at regular intervals for 30 min after injection using a published scale (Spangler et al., 1997) , and for specific behaviors (e.g., taffy pulling). Median scores (scale) or individual behavior sums for each mouse across the trial were used to calculate group averages.
COC CPP CPP (unbiased) consisted of a pretest, four alternating COC or SAL conditioning sessions, and a posttest, conducted on separate days. Food CPP was similar, except there were 12 alternating high-fat or regular chow conditioning sessions. Data are expressed as time in the reward-paired chamber minus time in the control-paired chamber during the posttest.
Fear Conditioning
Fear conditioning consisted of three 30 s tones that coterminated with a twosec (0.5 mA) shock (training). On subsequent days, mice were re-exposed to the same context (contextual test) and to the tone in a new context (cued test). Freezing was hand scored by an observer blind to genotype.
Sucrose Preference
After acclimation, individually housed mice were given four 24-hr periods of access to water and 1% sucrose in identical sipper tubes (test). Additional tests (4% and 0.5%) were performed after short periods of normal water access.
Stereotaxic Surgery
Anesthetized floxed Fmr1 mice received either AAV2-GFP or AAV2-CRE-GFP (1 ml per hemisphere; Vector Biolabs) bilaterally to the NAc (dorsal-ventral À4.4, medial-lateral +1.5, anterior-posterior +1.6). CPP began 20-21 days after surgery ( Figure 3B ).
Tissue Collection and Processing
Bilateral NAc and dorsal striata were individually dissected from coronal sections and processed by hemisphere for RT-PCR (Hale et al., 2011) or western blotting. For Golgi staining, brains were processed according to the manufacturer (FD Neurotechnologies), sliced (150 mm), and mounted. For immunohistochemistry, anesthetized mice were perfused intracardially with PBS and 4% paraformaldehyde. Brains were postfixed, cryoprotected, and sectioned (30 mm).
cAMP signaling Fmr1 KO and WT male mice were given five (13/day, i.p.) injections. Exposure was considered acute (SAL on days 1-4 and SAL or COC on day 5; 20 mg/kg) or chronic (SAL or COC on days 1-5; 20 mg/kg). Mice were sacrificed 20 min after the last dose.
Western Blotting
Equal amounts of protein were separated by SDS-PAGE and transferred to polyvinylidene fluoride membranes, which were blocked, rinsed, and incubated with primary and horseradish-peroxidase-conjugated secondary antibodies. Membranes were washed and developed using standard enhanced chemiluminescence and X-ray film.
Quantitative Real-Time PCR RNA isolation, reverse transcription, and quantitative real-time PCR were carried out as described elsewhere (Hale et al., 2011) . Fmr1 expression was determined by running reactions of 5 ng of cDNA and is expressed as fold change relative to GAPDH.
Dendritic Analyses
Unobstructed MSNs of the NAc core or shell (two to six per subregion per mouse) were traced bilaterally (403) using Neurolucida software (MBF Bioscience). Spines were counted (1003) from a single third order, or higher, complete terminal tip (R20 mM) and categorized by type. Quantitative assessment was performed using NeuroExplorer software (MBF Bioscience).
Immunohistochemistry/Injection Placement Sections were blocked and incubated with primary and secondary antibodies. Sections were counterstained, mounted, and assessed for placement. Mice with green fluorescent protein (GFP) staining outside the NAc, or with little or no GFP staining in the NAc, were removed.
Electrophysiology
Mice received daily injections (two SAL + five SAL or COC; 15 mg/kg). Twentyfour hours after the last dose, sagittal slices containing the NAc shell were prepared as described elsewhere (Thomas et al., 2001) . Briefly, MSNs were identified by typical morphology and voltage clamped at À80 mV. Recordings were performed in the presence of picrotoxin (100 mM) to block GABA A -mediated inhibitory postsynaptic currents. To assess excitatory synaptic neurotransmission, mEPSCs (amplitudes and frequencies) were collected in the presence of 0.7 mM lidocaine. For AMPA/NMDA ratio measurements, NAc afferents were stimulated to evoke AMPAR and NMDAR EPSCs in MSNs voltage clamped at +40 mv. The peak amplitude of AMPAR-mediated EPSCs was divided by the peak amplitude of NMDAR-mediated EPSCs. For PPR, two EPSC amplitudes were generated at À80 mV (interstimulus intervals: 20, 50, 100, and 200 ms). The peak amplitude of the second EPSC (P2) was divided by the peak of the first (P1) to generate the paired-pulse ratio (P2/P1).
Data Analysis
Statistical analyses/results are listed in Table S1 . Sensitization, stereotypy, and dendritic spine density data were initially analyzed by two-or three-way repeated-measures (RM) analyses of variance (ANOVAs) for each experiment/NAc subregion, as appropriate. Within-subjects variables were day and spine type, respectively; and between-subjects variables were genotype alone or Genotype 3 Treatment. Dendritic branch number and length were analyzed by separate three-way RM ANOVAs for each NAc subregion, with genotype and treatment as between-subjects variables and branch order as the within-subjects variable. CPP scores were analyzed by Independent Samples T test or two-way ANOVA, as appropriate. Overall spine density and P-Ser845 data were each analyzed by two-way ANOVAs. Significant interactions were followed by post hoc analyses or multivariate (MV)/univariate ANOVAs, as noted, to determine simple main effects. Locomotor challenge time points were analyzed by MV ANOVAs. All statistics were performed using either SPSS or GraphPad Prism software, remaining consistent within data set. Significance was set at alpha = 0.05. The Greenhouse-Geisser correction was applied whenever the data violated the sphericity assumption.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, five figures, and one table and can be found with this article online at http:// dx.doi.org/10.1016/j.neuron.2014.03.028.
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